Literature DB >> 6692497

Reduction of ischemic depolarization by the calcium channel blocker diltiazem. Correlation with improvement of ventricular conduction and early arrhythmias in the dog.

W T Clusin, M Buchbinder, A K Ellis, R S Kernoff, J C Giacomini, D C Harrison.   

Abstract

Calcium channel blockers suppress early ischemic arrhythmias, possibly by diminishing intracellular calcium overload and its effect on the ventricular action potential. To explore this, we compared the effects of diltiazem on ischemic "injury" potentials and ventricular fibrillation during serial coronary artery occlusions in dogs. Injury potentials and ventricular fibrillation were elicited every 15-25 minutes by simultaneous occlusion of the left anterior descending and circumflex arteries during rapid atrial pacing. DC epicardial electrograms were recorded differentially between the ischemic region and a small nonischemic region supplied by a proximal branch of the left anterior descending artery. Injury potentials developed with a uniform time course during five control occlusions, but were reduced by diltiazem infusion (0.5 mg/kg over 25 minutes) in each of eight dogs. The mean diastolic injury potential (T-Q depression) at 150 seconds of ischemia was 9.1 +/- 2.7 mV before diltiazem and 6.1 +/- 1.6 mV afterward (P less than 0.001). Diltiazem increased the mean time between coronary occlusion and ventricular fibrillation from 186 to 366 seconds (P less than 10(-5), but did not change the magnitude of the diastolic injury potential at onset of ventricular fibrillation. Diltiazem also delayed ischemia-induced conduction impairment to the same extent that it delayed injury potential development. In five dogs, the effect of diltiazem on regional blood flow near the epicardial electrodes was measured by infusion of radionuclide-labeled microspheres. Coronary occlusion reduced flow to the ischemic zone from 0.86 to 0.05 ml/min per g (P = 0.001). Diltiazem increased preocclusion flow by 11% (P = 0.03), but did not significantly alter flow during occlusion. Hemodynamic measurements show that diltiazem did not diminish cardiac work. Diltiazem therefore produced a flow-independent reduction of cellular depolarization during ischemia, which may be due to relief of calcium overload, and which may explain the antifibrillatory effect.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692497     DOI: 10.1161/01.res.54.1.10

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  14 in total

Review 1.  Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium.

Authors:  J A Lee; D G Allen
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Effects of the calcium antagonist gallopamil on the increase of myocardial extracellular potassium activity during LAD occlusion in dogs.

Authors:  M Budden; M Kirchengast; K M Zhang; W Meesmann
Journal:  Basic Res Cardiol       Date:  1987 May-Jun       Impact factor: 17.165

3.  Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia.

Authors:  Q Timour; B Bui-Xuan; G Faucon; J F Aupetit
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

4.  What is the solution to sudden cardiac death: calcium modulation or arrhythmia clinics?

Authors:  W T Clusin
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

5.  Attenuating loss of cardiac conduction during no-flow ischemia through changes in perfusate sodium and calcium.

Authors:  Gregory S Hoeker; Carissa C James; Allison N Tegge; Robert G Gourdie; James W Smyth; Steven Poelzing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-17       Impact factor: 4.733

6.  Spontaneous reversal of vertical diplopia in Graves' eye disease.

Authors:  B R Frueh; R S Benger
Journal:  Trans Am Ophthalmol Soc       Date:  1985

Review 7.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

8.  Cytosolic calcium transients from the beating mammalian heart.

Authors:  H C Lee; N Smith; R Mohabir; W T Clusin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

9.  Attenuation of reperfusion-induced ventricular fibrillation in the rat isolated hypertrophied heart by preischemic diltiazem treatment.

Authors:  G F Baxter; D M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

10.  Mechanism of depolarization in the ischaemic dog heart: discrepancy between T-Q potentials and potassium accumulation.

Authors:  K Blake; W T Clusin; M R Franz; N A Smith
Journal:  J Physiol       Date:  1988-03       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.